Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1 load quantitation: a 17-year perspective.

Mark Holodniy1

  • 1AIDS Research Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA. mark.holodniy@va.gov

The Journal of Infectious Diseases
|August 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanding Horizons: Host Range Evolution and Treatment Strategies for Highly Pathogenic Avian Influenza H5N1 and H7N9.

Viruses·2026
Same author

Health Care Costs Associated With Norovirus at the Veterans Health Administration.

JAMA network open·2025
Same author

Bacteremic vs Nonbacteremic <i>Shigella</i> Infections in the United States Veterans Health Administration, 2000-2024.

Open forum infectious diseases·2025
Same author

Establishment of the Veterans Affairs SeqFORCE (Sequencing for Research Clinical and Epidemiology) program for SARS-CoV-2 whole-genome sequencing.

American journal of clinical pathology·2025
Same author

Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC<sup>3</sup>)-Database of a prospective longitudinal observational study within the Veterans Health Administration.

Frontiers in public health·2025
Same author

Genomic Characterization of RSV in the US by Vaccination Status.

JAMA·2025

Quantifying human immunodeficiency virus type 1 (HIV-1) RNA levels, or HIV-1 load, is crucial for tracking disease progression and assessing antiretroviral therapy effectiveness. Advances in HIV-1 load testing have significantly impacted clinical practice.

Area of Science:

  • Virology
  • Immunology
  • Clinical Medicine

Background:

  • Plasma-associated human immunodeficiency virus type 1 (HIV-1) RNA level, or HIV-1 load, has become a vital marker in managing HIV-1 infection over the last 15 years.
  • It serves as a surrogate for disease progression and a measure of antiretroviral therapy efficacy.

Purpose of the Study:

  • To review the historical development and impact of HIV-1 load quantification in clinical practice.
  • To highlight the contributions of Tom Merigan's laboratory to HIV-1 load monitoring and technology.
  • To discuss the performance, interpretation, and clinical application of HIV-1 load testing.

Main Methods:

  • Review of historical data and clinical trial outcomes related to HIV-1 load.
  • Analysis of technological advancements in HIV-1 RNA quantitation.

Related Experiment Videos

  • Evaluation of the interpretation and clinical utility of HIV-1 load results.

    • Main Results:

    • HIV-1 load quantitation is a validated surrogate marker for HIV-1 disease progression.
    • It effectively measures the potency and durability of antiretroviral regimens.
    • Technological improvements have enhanced the accuracy and utility of HIV-1 load testing.

    Conclusions:

    • The use of HIV-1 load has revolutionized HIV-1 management and treatment monitoring.
    • Continued advancements in testing technologies further refine clinical decision-making.
    • Tom Merigan's laboratory played a significant role in establishing HIV-1 load as a cornerstone of HIV-1 care.